High-Dose Barium Enemas Prevent Recurrent Diverticular Bleeding

Clinical question Does barium impaction therapy using high-dose barium enemas prevent recurrent diverticular bleeding? Bottom line This small study demonstrates that barium impaction therapy using high-dose barium enemas is safe and effective at reducing the rate of recurrent diverticular bleeding. Note that this study was conducted in Japan, where the rate of rebleeding for patients… [Read More]

Steroids May Benefit Patients With Severe CAP and High CRP Levels

Clinical question: Do steroids improve outcomes in patients with severe community-acquired pneumonia and a high inflammatory response? Bottom line In patients with severe community-acquired pneumonia (CAP) who have elevated levels of C-reactive protein (CRP), a short course of methylprednisolone decreases treatment failure, mainly by reducing radiographic progression of pulmonary infiltrates within 3 days to 5… [Read More]


Palliative Care and Last-Minute Heroics

4/8/15 Session: Last-Minute Heroics and Palliative Care – Do They Meet in the Middle? HM15 Presenter: Tammie Quest, MD Summation: Heroics- a set of medical actions that attempt to prolong life with a low likelihood of success. Palliative care- an approach of care provided to patients and families suffering from serious and/or life limiting illness;… [Read More]


Hot Topics in Practice Management; HM15 Session Analysis

HM15 Session  RAPID FIRE PANEL: Hot Topics in Practice Management Updates on Key Issues, Including the Key Characteristics of an Effective HMG HM15 Presenters: Roy Sittig MD SFHM, Jeffrey Frank MD MBA, Jodi Braun Summation: Speakers covered timely topics regarding the Accountable Care Act, namely Medicaid Expansion and Bundled Payment arrangements; and reviewed the seminal paper… [Read More]

Hospital Management of Patients Presenting with ALTE: An Evidence-Based Approach

In a presentation on guidelines for ALTE, Jack Percelay, SHM representative to the AAP Subcommittee, provided further insight to the work that has been done for the clinical entity known as apparent life-threatening events (ALTE) since a consensus statement was put forward by the NIH in 1986. The original statement emphasized 4 possible features to constitute… [Read More]

Fondaparinux for Treatment of Heparin-Induced Thrombocytopenia

Clinical question: Is fondaparinux as safe and effective as argatroban and danaparoid in treating heparin-induced thrombocytopenia (HIT)? Background: Guidelines for the treatment of HIT recommend using danaparoid (factor Xa inhibitor), argatroban, or lepirudin (both direct thrombin inhibitors). Reduced availability, cost, and complexity of administration limit these options, and fondaparinux is often used off label in… [Read More]